about
Effects of lung surfactant proteins, SP-B and SP-C, and palmitic acid on monolayer stability.Surfactant replacement therapy--room for improvement.Interaction of lung surfactant proteins with anionic phospholipids.Electrostatic barrier to recovery of dipalmitoylphosphatidylglycerol monolayers after collapseFatty acid intake and the risk of community-acquired pneumonia in U.S. womenDelivery and performance of surfactant replacement therapies to treat pulmonary disorders.Multilayer structures in lipid monolayer films containing surfactant protein C: effects of cholesterol and POPE.Aerosolizing Lipid Dispersions Enables Antibiotic Transport Across Mimics of the Lung Airway Surface Even in the Presence of Pre-existing Lipid Monolayers.
P2860
Q28363708-3086CA87-F8BF-43B3-9084-FEF9888F29F6Q33608091-5D9F74AE-B98D-4640-A3C9-5FABBA86DA12Q34175840-58536BC5-55C3-41DC-AE4A-FEBFEDC6619FQ34184833-B7FAB582-A94E-4B3E-859B-AC6F8916C630Q36540672-7609B135-0A0B-4A4B-9ABB-FF4A5EAEAC73Q37341712-DD673BCC-73E4-4645-90CB-432DB56BD289Q40324788-3F3E7E17-E06F-49AD-95D3-1E7C1506383AQ47426647-2D59C6E3-EFCD-448E-97EB-FD887D53EB9B
P2860
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Pulmonary surfactant therapy.
@ast
Pulmonary surfactant therapy.
@en
type
label
Pulmonary surfactant therapy.
@ast
Pulmonary surfactant therapy.
@en
prefLabel
Pulmonary surfactant therapy.
@ast
Pulmonary surfactant therapy.
@en
P2860
P1476
Pulmonary surfactant therapy
@en
P2093
F R Poulain
J A Clements
P2860
P407
P577
1995-01-01T00:00:00Z